Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joy Gumin

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Neuro-Oncology|June 1, 2021
An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirusLynette M Phillips, Shoudong Li, Joy Gumin, et al.
Cancers|February 25, 2023
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with VerteporfinJiyong Liang, Dexing Fang, Joy Gumin, et al.
Cancer Research|September 1, 2017
Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587Javier Figueroa, Lynette M Phillips, Tal Shahar, et al.
Cells|October 23, 2021
Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic ResonanceTravis C Salzillo, Vimbai Mawoneke, Joseph Weygand, et al.
Plos One|May 16, 2014
Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse modelHong Jiang, Karen Clise-Dwyer, Kathryn E Ruisaard, et al.
Stem Cells (Dayton, Ohio)|January 10, 2012
REST regulates oncogenic properties of glioblastoma stem cellsMohamed M Kamal, Pratheesh Sathyan, Sanjay K Singh, et al.
Neuro-Oncology|October 17, 2023
Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastomaMalcolm F McDonald, Anwar Hossain, Eric N Momin, et al.
Stem Cells (Dayton, Ohio)|May 14, 2015
Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 PathwayAnwar Hossain, Joy Gumin, Feng Gao, et al.
Oncotarget|August 27, 2015
Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targetingVeerakumar Balasubramaniyan, Brian Vaillant, Shuzhen Wang, et al.
Neurosurgery|November 24, 2020
Endovascular Selective Intra-Arterial Infusion of Mesenchymal Stem Cells Loaded With Delta-24 in a Canine ModelVisish M Srinivasan, Joy Gumin, Kevin M Camstra, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Neuro-Oncology|June 1, 2021
An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirusLynette M Phillips, Shoudong Li, Joy Gumin, et al.
Cancers|February 25, 2023
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with VerteporfinJiyong Liang, Dexing Fang, Joy Gumin, et al.
Cancer Research|September 1, 2017
Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587Javier Figueroa, Lynette M Phillips, Tal Shahar, et al.
Cells|October 23, 2021
Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic ResonanceTravis C Salzillo, Vimbai Mawoneke, Joseph Weygand, et al.
Plos One|May 16, 2014
Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse modelHong Jiang, Karen Clise-Dwyer, Kathryn E Ruisaard, et al.
Stem Cells (Dayton, Ohio)|January 10, 2012
REST regulates oncogenic properties of glioblastoma stem cellsMohamed M Kamal, Pratheesh Sathyan, Sanjay K Singh, et al.
Neuro-Oncology|October 17, 2023
Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastomaMalcolm F McDonald, Anwar Hossain, Eric N Momin, et al.
Stem Cells (Dayton, Ohio)|May 14, 2015
Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 PathwayAnwar Hossain, Joy Gumin, Feng Gao, et al.
Oncotarget|August 27, 2015
Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targetingVeerakumar Balasubramaniyan, Brian Vaillant, Shuzhen Wang, et al.
Neurosurgery|November 24, 2020
Endovascular Selective Intra-Arterial Infusion of Mesenchymal Stem Cells Loaded With Delta-24 in a Canine ModelVisish M Srinivasan, Joy Gumin, Kevin M Camstra, et al.
Pageof 7